Skip to main content

Cervical Cancer Screening in Arab Countries

  • Living reference work entry
  • First Online:
Handbook of Healthcare in the Arab World
  • 77 Accesses

Abstract

Approximately half million women developed cervical cancer each year, and half of this number die as a result of this diseases each year. Eighty percent of the burden of cervical cancer occurs in developing countries with no prevention and screening cancer programs. Almost all cases of cervical cancer develop secondary to infection with human papillomavirus (HPV) which does affect 80% of sexually active women at one stage. HPV is the most common sexually transmitted infection (STI). Most women who get the HPV infection will clear the infection by themselves; however, the infection might persist in few women. It is the persistent high-risk HPV infection (mainly HPV 16 and 18) which caused cervical cancer. There are 14,280 new cases of cervical cancer in the Arab region in 2018 with 9,354 deaths. There is no single strategy that can be applied across all Arab countries due to variations in resource, demography, and the burden of cervical cancer in each country. Arab countries with high resources can adopt both organized screening program and HPV vaccination; however, in low-resource Arab countries, HPV vaccination in collaboration with funding agencies such as Gavi allies might be the best cervical cancer intervention strategy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Similar content being viewed by others

References

  • Al Sairafi M, Mohamed F (2009) Knowledge, attitudes, and practice related to cervical l cancer screening among Kuwaiti women. Med Princ Pract 18(1):35–42

    Article  Google Scholar 

  • Al Zaabi M, Al Muqbali S, Al Sayadi T, Al Ameeri S, Ortashi O (2015) Age specific cytological abnormalities in women screened for cervical Cancer in the Emirate of Abu Dhabi. Asian Pac J Cancer Prev 16(15):6375–6379

    Article  Google Scholar 

  • Alemany L (2015) Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. Int J Cancer 136(1):98–107

    Article  CAS  Google Scholar 

  • Ali M, Bedair R, El Atti A (2019) Cervical high-risk human papillomavirus infection among women residing in the Gulf Cooperation Council countries: prevalence, type-specific distribution, and correlation with cervical cytology. Cancer Cytopathol 127(9):567–577

    Article  Google Scholar 

  • Al-Meer FM (2011) Knowledge, attitude and practices regarding cervical cancer and screening among women visiting primary health care in Qatar. East Mediterr Health 17(11):855–861

    CAS  Google Scholar 

  • Arbyn MW (2020) Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health 8(2):191–e203

    Article  Google Scholar 

  • Atashili JP (2007) Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS 22, 1493–1501. AIDS 22:1493–1501

    Article  Google Scholar 

  • Bosch FM (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 87(11):796–802

    Article  CAS  Google Scholar 

  • Breitburd F, Kirnbauer R, Hubbert N, Nonnenmacher R (1995) Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J Virol 69(6):3959–3963

    Article  CAS  Google Scholar 

  • Brotman RM (2010) Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial and trichomonal genital infection. J Infect Dis 202:1907–1915

    Article  Google Scholar 

  • Chokunonga E, Ramanakumar A, Nyakabau A (2003) Survival of cervix cancer patients in Harare, Zimbabwe, 1995–1997. Br J Cancer 3(89):65–69

    Google Scholar 

  • DeSanjosé (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 11(11):1048–1056

    Article  Google Scholar 

  • deSanjosé S (2013) Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. Eur J Cancer 49(16):3450–3461

    Article  Google Scholar 

  • Ghazal-Aswad S, Gargash H (2006) Cervical smear abnormalities in the United Arab Emirates: a pilot study in the Arabian Gulf. Acta Cytol 50(1):41–47

    Article  Google Scholar 

  • Gullen T (1900) Cancer of the Uterus: its pathology, symptomatology, diagnosis and treatment, 1st edn. Appleton, New York

    Google Scholar 

  • Hausen H, Meinhof W, Scheiber W, Bornkamm G (1974) Attempts to detect virus-specific DNA in human tumors. I. Nucleic acid hybridizations with complementary RNA of human wart virus. Int J Cancer 13(5):650–656

    Article  Google Scholar 

  • Health TC (2018) HPV and cervical cancer in the MENA region. Retrieved 10 Jan 2020, from https://tuncph.org/en/

  • IARC (International Agency for Research on Cancer) (2012) A review of human carcinogens. Bookshelf, Lyon

    Google Scholar 

  • Ibrahim A, Aro A, Rasch V, Pukkala E (2012) Cervical cancer screening in primary health care setting in Sudan: a comparative study of visual inspection with acetic acid and Pap smear. Int J Womens Health 2(4):67–73

    Article  Google Scholar 

  • Joura E (2014) Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease. Cancer Epidemiol Biomarkers Prev 23(10):1997–2008

    Article  Google Scholar 

  • Khazraji C (2012) International conference on cancer control in Middle-East and Africa. Working group 2: early detection of cervical cancer. Marrakech. Available at: http://www.contrelecancer.ma

  • Kim JS-G (2013) Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA). Vaccine 31:G65–G77

    Article  Google Scholar 

  • Louie K, de Sanjose S, Mayaud P (2009) Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review. Trop Med Int Health 14(1):287–301

    Google Scholar 

  • Marc A (2020) Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health 19(30482):191–203

    Google Scholar 

  • Martinez G, Copen C, Abma J (2011) Teenagers in the United States: sexual activity, contraceptive use, and childbearing, 2006–2010 National Survey of Family Growth. Vital Health Stat 23(31):1–35

    Google Scholar 

  • Moscicki A, Schiffman M, Kjaer S, Villa L (2006) Updating the natural history of HPV and anogenital cancer. Vaccine 24(S3):42–51

    Article  Google Scholar 

  • Naz U, Hanif S (2014) Agreement between visual inspection with acetic acid and Papanicolaou’s smear as screening methods for cervical cancer. J Coll Physicians Surg Pak 24(4):228–231

    PubMed  Google Scholar 

  • Norenhag J, Du J, Olovsson M, Verstraelen H (2020) The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis. BJOG 127(2):171–180

    Article  CAS  Google Scholar 

  • Ortashi O, Shallal M, Osman N, Raheel H (2012) Knowledge, attitude and practice of school nurses in the United Arab Emirates about HPV infection and vaccine. Asian Pac J Cancer Prev 13(12):6481–6484

    Article  Google Scholar 

  • Ortashi O, Raheel H, Shalal M, Osman N (2013a) Awareness and knowledge about human papillomavirus infection and vaccination among women in UAE. Asian Pac J Cancer Prev 14(10):6077–6080

    Article  Google Scholar 

  • Ortashi O, Raheel H, Khamis J (2013b) Acceptability of human papillomavirus vaccination among male university students in the United Arab Emirates. Vaccine 31(44):5141–5144

    Article  Google Scholar 

  • Papanicolaou G, Traut H (1941) The diagnostic value of vaginal smears in carcinoma of the uterus. Am J Obstet Gynecol 42(2):193–206

    Article  Google Scholar 

  • Parkin DM, Bray F (2002) Global cancer statistics, 2002. Cancer J Clin 55:74–108

    Article  Google Scholar 

  • Parkin D, Whelan S, Ferlay J (2002) Cancer incidence in five continents, vol VIII. IARC No.155. Scientific Publication, Lyon

    Google Scholar 

  • Sait KH (2009) Knowledge, and practices in relation to cervical cancer and its screening among women in Saudi Arabia. Saudi. Saudi Med J 30(9):1208–1212

    PubMed  Google Scholar 

  • Schiffman M, Castle P, Jeronimo J, Rodriguez A (2007) Human papillomavirus and cervical cancer. Lancet 370(9590):890–907

    Article  CAS  Google Scholar 

  • Walboomers J, Jacobs MV, Manos M, Bosch FX (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 98(1):10451482

    Google Scholar 

  • Wellings K, Collumbien M, Slaymaker E, Singh S (2006) Sexual behaviour in context: a global perspective. Lancet 368(9548):1706–1728

    Article  Google Scholar 

  • Zare E, Roozbeh N, Akbari PA, Teshnizi SH, Ghazanfarpour M, Abdi F (2020) HPV and its high-risk genotypes in Middle Eastern countries: a meta-analysis. Future Virology 15(9):595–607

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Ortashi, O., Alkalbani, M. (2021). Cervical Cancer Screening in Arab Countries. In: Laher, I. (eds) Handbook of Healthcare in the Arab World. Springer, Cham. https://doi.org/10.1007/978-3-319-74365-3_16-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-74365-3_16-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-74365-3

  • Online ISBN: 978-3-319-74365-3

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics